comparemela.com

Zhou Dongyan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy

HKUMed researchers at AIDS Institute, Department of Microbiology and Department of Surgery, School of Clinical Medicine, and School of Biomedical Sciences discover the role of an isoformic programmed cell death protein 1 (PD-1), namely Δ42PD-1, in suppressing the function of killer T cells, which is a type of immune cells essential for killing cancer cells among hepatocellular carcinoma (HCC) patients.

HKUMed found that robust SARS-CoV-2 infection in nasal turbinate underlies incomplete protection by systemic antibody or vaccine

HKUMed found that robust SARS-CoV-2 infection in nasal turbinate underlies incomplete protection by systemic antibody or vaccine
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.